The Insider For DENTSPLY SIRONA Inc. (XRAY) Sold 6,900 Shares.

The stock of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) decreased by -$0.4 on Tuesday to finish at $38.10, down -1.04 percent. The last five days have seen an average of 1,882,700 shares of common stock traded. 4 times new highs were reached in the current year, with a fall of -$17.69. The average number of shares traded over the last 20 days was 2,659,495, while the average volume over the last 50 days totaled 2,595,844.

XRAY stock dropped -8.26% since last month. On 05/10/22, the company’s shares reached a one-month low of $35.00. The stock touched a high of $68.02 on 02/25/22, after rallying from a low of $35.00 in 52 weeks. The price of XRAY stock has declined by -31.71% or -$17.69 this year, reaching a new high 4 times. Still, the stock price is down -43.99% from the 52-week high.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Insider Transactions

There have been 22 days since DENTSPLY SIRONA Inc. (XRAY) last reported insider trading activity on May 03. On May 03, Director BRANDT ERIC sold 6,900 shares at $39.71 each. This transaction resulted in the insider making $273,999. On Dec 01, Casey Donald M Jr. added 20,000 shares at a price of US$49.78. After the transaction, the insider now owns 52,500 shares. Sr VP & Chief HR Officer Yankie Lisa had earlier sold 1,903 shares on Nov 19 for $52.63 a share. The transaction was completed for $100,155.

Valuation Metrics

DENTSPLY SIRONA Inc. (XRAY) has a trailing price-to-earnings (P/E) ratio of 22.67. Beta for the stock is 0.94. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 1.94, the price-to-book (PB) ratio of 1.65, and the price-to-cash flow ratio of 16.89.

Company paid $0.1250 per share in dividends, an increase of 13.64% from $0.11 last year. A $0.0150 dividend increase was reported on Thursday March 3 2022.

Financial Health

For the three months ended March 30, DENTSPLY SIRONA Inc.’s quick ratio was 1.10, while its current ratio was 1.50, indicating its ability to pay off its debt. The company’s long-term debt to equity ratio for the quarter ending March 30 is 0.38, and the total debt to equity ratio is 0.42. As far as profitability goes, gross margin for the trailing twelve months is 54.80% percent. DENTSPLY SIRONA Inc.’s operating margin stood at 14.70% for the same period. Based on annual data, it had gross profit of $2.36 billion and revenue of $4.25 billion.

Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. XRAY’s return on assets (ROA) during the last 12 months has been 4.50%. There was a 6.90% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was 8.30%.

Earnings Surprise

According to DENTSPLY SIRONA Inc.’s quarterly financial report for the quarter that ended March 30. A lower net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $1.09 billion, while revenues rose by 17.76% to $1.07 billion. It was predicted that DENTSPLY SIRONA Inc.’s quarterly earnings would be $0.52, but it ended up being $0.56, beating the consensus by -7.10%. At the end of DENTSPLY SIRONA Inc.’s most recent quarter ended March 30, its liabilities totaled 4.25 billion, while its total debt was $2.3 billion.

Technical Picture

Here’s a quick look at DENTSPLY SIRONA Inc.’s (XRAY) price momentum from a technical perspective. As of 24 May, the RSI 9-day stood at 41.42%, suggesting the stock is Neutral, with a 25.79% historical volatility rate.

The stochastic %K and %D were 44.03% and 40.20% respectively, while the average true range (ATR) was 1.23. Based on the 14-day stochastic reading of 43.80%, the RSI (14) reading is 37.84%. On the 9-day MACD Oscillator, the stock is at 0.05, and the 14-day reading is at -0.26.

Analyst Ratings

DENTSPLY SIRONA Inc. (NASDAQ: XRAY) was downgraded by William Blair to a a Mkt perform rating in its latest research report. The stock was previously rated as a an Outperform. Analysts have assigned DENTSPLY SIRONA Inc. (XRAY) an Overweight rating. XRAY is a stock that is recommended for selling by 0 brokerage firms, while 9 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 0 rates it overweight and 4 others recommend it as a buy.


Please enter your comment!
Please enter your name here

Hot Topics

Related Articles




Download Free eBook For

The 5 Best Growth Stocks 2022

100% free. stop anytime no spam